Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol

  • ReseaRch aRticle
  • Published 2011

Abstract

Since their discovery [1], glucocorticoids have been used to treat rheumatoid arthritis (RA) through powerful anti-inflammatory [2,3] and antierosive [4,5] properties. In RA, symptoms such as pain, early-morning joint stiffness and joint swelling have a circadian rhythm, with maximum activity in the morning and minimum activity in the afternoon [6,7]. This phenomenon, often described as early-morning stiffness (EMS), is so characteristic of RA that it is considered a basic feature pointing to inflammatory polyarthritis [8]. The synovitis of RA is driven in part by deregulation of the inflammatory process and production of proinflammatory cytokines such as IL-6 and TNF [9]. Early studies by Arvidson et al. demonstrated that overnight plasma IL-6 is reduced by 15–20 mg of prednisolone [10] and that lower doses (5–7.5 mg) are more effective at lowering early-morning IL-6 when given at 2 am compared with 7 am [11]. In a recent clinical trial, Buttgereit et al. tested the timed-release formulation of prednisone in patients with RA against standard-release prednisone given in the morning [12]. In this timed-release tablet (TRT) formulation, prednisone is released into the gut lumen 4 h (±15 min) after ingestion. This allows patients to take the medication at 10 pm (before going to bed), while drug delivery occurs at 2 am, similar to the Arvidson study but without the need to wake the patients [13]. A significant reduction in early-morning joint stiffness was detectable in the TRT group after 2 weeks and was sustained for 12 weeks. In single morning blood samples taken at 12 weeks, IL-6 was also reduced. A wide range of systemic proinflammatory actions have been ascribed to IL-6 [14]. In RA patients, IL-6 is substantially elevated in serum and synovial fluid compared with healthy controls [15,16]. Serum IL-6 shows a clear circadian pattern of secretion, with a markedly exaggerated overnight peak reaching a maximum Aim: The effect of prednisone on the morning joint stiffness of rheumatoid arthritis (RA) is enhanced by night-time (2 am) administration. It has been hypothesized that this may be due to suppression of the pathological early-morning rise in plasma IL-6, but this has not yet been measured. A theoretical disadvantage of night-time prednisone is increased suppression of the hypothalamic–pituitary–adrenal axis and reduced peak plasma cortisol levels, usually attained at approximately 7 am. This study measured 24-h variations in IL-6, other cytokines and cortisol in patients before and after a 2-week course of nighttime prednisone to address both these questions. Materials & methods: Nine patients with active RA were clinically assessed and had 24-h blood sampling before and after a 2-week course of timed-release tablet (TRT) prednisone (5 mg per day). Patients took the TRT orally at 10 pm and the prednisone was released at 2 am. Changes in circadian variation in cortisol and IL-6 and clinical measures were compared using regression modeling and Wilcoxon matched-pairs signed-rank test. Cytokines IL-1 receptor antagonist, IL-1b, IL-4 and TNF were also measured. Results: Significant alterations in the circadian profiles and concentrations of IL-6 and cortisol were observed following TRT prednisone. The estimated peak value of IL-6 fell from 42.2 to 21.3 pg/ml and occurred earlier (8:05 am compared with 1:21 am; p < 0.005). Following TRT prednisone, the peak value of cortisol increased from 14.1 to 19.3 μg/dl and the trough fell from 2.9 to 2.1 μg/dl (p < 0.001). Clinical symptoms, particularly morning stiffness (p = 0.028), were reduced, but in three patients with high concentrations of IL-1 receptor antagonist, IL-1b, IL-4 and TNF, neither IL-6 nor morning stiffness changed. Conclusion: Prednisone released at 2 am does suppress the pathological earlymorning rise in plasma IL-6 in RA. The nocturnal rise in plasma cortisol was not suppressed but was enhanced, consistent with a changing relationship between hypothalamic–pituitary–adrenal axis and immune system activation. A subset of patients with high concentrations of several cytokines did not respond to prednisone.

5 Figures and Tables

0204060201220132014201520162017
Citations per Year

86 Citations

Semantic Scholar estimates that this publication has 86 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{aRticle2011AlleviationOM, title={Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol}, author={ReseaRch aRticle}, year={2011} }